Sign in to continue:

Saturday, May 2nd, 2026

Modiv Inc. 2025 10-K/A Filing: Executive Compensation, Ownership, Governance, and Audit Details




Key Highlights and Investor Analysis: Modiv Industrial, Inc. 10-K/A (Amendment No. 1) for FY2025

Modiv Industrial, Inc. Files 10-K/A Amendment No. 1: Key Details for Shareholders

Overview

Modiv Industrial, Inc. (“Modiv” or the “Company”) has filed Amendment No. 1 to its Annual Report on Form 10-K for the fiscal year ended December 31, 2025. This amendment is significant as it provides updated disclosures required under Part III of Form 10-K, which typically include information about executive compensation, security ownership, and corporate governance. Notably, this update occurs because the Company does not expect to file its definitive proxy statement within 120 days after year-end.

Key Points and Shareholder-Relevant Highlights

1. No Material Financial Restatements or Corrections

  • The amendment specifically states that there are no corrections of errors to previously issued financial statements, and there are no restatements requiring recovery analysis of executive compensation.

2. Executive Compensation and Corporate Governance

  • Named Executive Officers for 2025 and 2024:

    • Aaron S. Halfacre (Chief Executive Officer and President)
    • Raymond J. Pacini (Executive Vice President, Chief Financial Officer, Secretary and Treasurer)
    • John C. Raney (Chief Operating Officer and General Counsel)
  • CEO Salary Changes: Notably, Mr. Halfacre ceased drawing a salary effective April 1, 2025, in connection with a grant of Class C OP Units, which could be a move toward equity-based compensation.
  • Compensation Table Highlights (2025):

    • Aaron S. Halfacre: \$85,203 (bonus), plus significant stock awards.
    • John C. Raney: \$285,000 (salary), with additional compensation in stock awards.
  • Outstanding Equity Awards: As of December 31, 2025, substantial equity awards remain outstanding for executives, which could impact future dilution or align management incentives with shareholders.

3. Share Ownership and Major Shareholders

  • Shares Outstanding: As of April 30, 2026, there were 10,323,670 shares of Class C common stock outstanding.
  • Major Shareholders:

    • First City Investment Group, LLC: 4.2% ownership
    • BlackRock, Inc.: 4.1% ownership
    • Directors and officers as a group: 12.6% ownership
  • Note: No shares of common stock held by directors and executives are pledged as security, which may be seen as a positive governance factor.

4. Equity Compensation Plans

  • Securities to be issued upon exercise of equity compensation plans: 895,043 shares under approved plans, with 88,690 shares remaining available for future issuance.
  • No equity compensation plans not approved by security holders.

5. Audit Committee, Code of Ethics, and Insider Trading Policy

  • Audit Committee: Composed entirely of independent directors, chaired by Mr. Nolan (who also qualifies as a financial expert under SEC rules).
  • Code of Business Conduct and Ethics & Insider Trading Policy: Both are in place and apply to all directors, officers, and employees. The Insider Trading Compliance Policy includes blackout periods post-earnings and event-driven restrictions in compliance with NYSE standards.

6. No Changes to Financial Statements or Internal Control Attestations

  • This amendment does not include any new or amended financial statements, nor updates on internal control over financial reporting. No Section 906 certifications are included since no financials were restated or updated.

7. Key Exhibits Included

  • Amended certifications by the CEO and CFO under Section 302 of Sarbanes-Oxley are included as exhibits, fulfilling current legal requirements.
  • All governance and plan documents are referenced and available via SEC filings.

Potential Price-Sensitive Factors

  • Shift in Executive Compensation Structure: The shift of the CEO from a cash salary to a grant of Class C OP Units may indicate a stronger alignment with shareholder interests, potentially signaling confidence in the Company’s prospects or a focus on equity-based performance incentives.
  • Updated Ownership Disclosures: The disclosure of major shareholders and the relatively high insider ownership (12.6%) may be interpreted as a positive sign by investors seeking alignment between management and shareholders.
  • No Financial Restatements: The absence of material financial restatements or corrections assures investors of the integrity of previously reported financials, reducing uncertainty.
  • Equity Awards and Potential Dilution: The significant number of outstanding equity awards could lead to future share dilution, which is important for valuation models.

Conclusion and Investor Takeaways

This 10-K/A amendment from Modiv Industrial, Inc. is primarily administrative and governance-related, with no direct restatements or corrections to financial statements. The most notable developments are the changes to executive compensation (especially the CEO’s move to equity-based pay), the solid insider and institutional ownership, and the lack of any negative surprises regarding governance or financial controls. There are no dramatic revelations; however, the alignment of management incentives with shareholders and the transparent reporting on ownership and equity compensation may be viewed positively by long-term investors.

Disclaimer


This article is for informational purposes only and does not constitute investment advice or a recommendation to buy or sell any securities. Investors should conduct their own due diligence and consult a qualified financial advisor before making investment decisions. The information herein is based on publicly available filings and may be subject to change or update.




View MODIV INDUSTRIAL, INC. Historical chart here



Annovis Bio Announces $10 Million Underwritten Offering to Advance Alzheimer’s and Parkinson’s Drug Development

Annovis Bio Announces \$10 Million Equity Offering: Key Deta...

Scorpius Holdings, Inc. 2024 Audited Financial Statements: Revenue, Debt, Going Concern, and CDMO Operations Analysis

Scorpius Holdings, Inc. 2024 Audited Financial Results: Key ...

Aspire Biopharma Holdings: Innovative Patent-Pending Sublingual Drug Delivery & Product Pipeline Overview

Aspire Biopharma Holdings, Inc. Files Amended 10-K/A: Key De...

   Ad

Join Our Investing Seminar

Limited seats available — Reserve your spot today